Notify me when IAF, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | Common Stock, par value $0.005 per share | 5.2% | $683,638 | +$121,003 | 3,255,421 | +22% | IAF, LLC | 31 Mar 2025 |
| ERNA | Ernexa Therapeutics Inc. | Common Stock, par value $0.005 per share | 4.1% | $584,191 | 315,779 | IAF, LLC | 28 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|